| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/01/2001 | WO2001006854A1 System and methods for local intradermal treatment |
| 02/01/2001 | WO2000074648A3 Prevention of regression in refractive keratoplasty |
| 02/01/2001 | WO2000063248A3 Highly purified gonadotropin compositions and process for preparing them |
| 02/01/2001 | WO2000061116A3 Pharmaceutical formulation comprising amoxycillin and clavulanate |
| 02/01/2001 | WO2000059518A3 Composition and method for inducing apoptosis in prostate cancer cells |
| 02/01/2001 | WO2000056362A3 Polycationic carbohydrates as immunostimulants in vaccines |
| 02/01/2001 | WO2000053161A3 Microparticles for delivery of nucleic acid |
| 02/01/2001 | WO2000033818A9 Sustained release tablet containing hydrocolloid and cellulose ether |
| 02/01/2001 | WO2000013678A9 Extended release acetaminophen |
| 02/01/2001 | WO1999065461A9 Cationic amphiphile micellar complexes |
| 02/01/2001 | WO1998034604A8 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN |
| 02/01/2001 | DE19934945A1 Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen Cosmetic and dermatological preparations based on O / W emulsions |
| 02/01/2001 | DE19934943A1 Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen Cosmetic and dermatological preparations based on O / W emulsions |
| 02/01/2001 | DE19934894A1 Collagen particles for use as drug carriers, e.g. for administration of proteins or peptides by injection, prepared from emulsion containing collagen solution or dispersion without using crosslinking agents |
| 02/01/2001 | CA2689694A1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/01/2001 | CA2379815A1 Parenteral cisplatin emulsion |
| 02/01/2001 | CA2378377A1 Method for releasing an agent from a red blood cell |
| 02/01/2001 | CA2378372A1 Oil-in-water emulsion with improved stability |
| 02/01/2001 | CA2377024A1 Ophthalmic composition comprising ketotifen |
| 01/31/2001 | EP1072633A1 Pullulan film compositions |
| 01/31/2001 | EP1072617A1 Temperature sensitive polymers |
| 01/31/2001 | EP1072612A1 Starch granulation |
| 01/31/2001 | EP1072269A1 Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof |
| 01/31/2001 | EP1072268A1 Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof |
| 01/31/2001 | EP1072262A1 Dispersible fluoxetine tablet |
| 01/31/2001 | EP1072261A2 Felbinac-containing patch |
| 01/31/2001 | EP1072260A1 Transdermal systems for the release of muscarinic receptor antagonists and use thereof for treatement of smooth muscle spasms in urology |
| 01/31/2001 | EP1072259A2 Microcapsule and method of making the same |
| 01/31/2001 | EP1072258A1 Capsule for the release of bacteria, containing lyophilised bacteria and a method for the production thereof |
| 01/31/2001 | EP1072257A1 Multiple-unit sustained release tablets |
| 01/31/2001 | EP1072256A1 Tablets quickly disintegrating in the oral cavity and process for producing the same |
| 01/31/2001 | EP1072255A2 Desferrioxamine oral delivery system |
| 01/31/2001 | EP1072249A2 Cosmetic and dermatological compositions based on w/o emulsions |
| 01/31/2001 | EP1072246A2 Cosmetic and dermatological compositions based on o/w emulsions |
| 01/31/2001 | EP1072198A1 Preparation especially for use as medicament and/or nutritional supplement |
| 01/31/2001 | EP1071485A2 Revascularization apparatus having coaxial channeling and injection means |
| 01/31/2001 | EP1071481A1 Preparation for regenerating collagen |
| 01/31/2001 | EP1071466A1 Glycolipid creams |
| 01/31/2001 | EP1071465A1 Amorphous glasses for stabilising sensitive products |
| 01/31/2001 | EP1071464A2 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders |
| 01/31/2001 | EP1071462A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 01/31/2001 | EP1071457A1 Polymer particle vaccine delivery system |
| 01/31/2001 | EP1071448A1 Use of protease inhibitors for treating skin wounds |
| 01/31/2001 | EP1071445A2 Therapeutic angiogenic factors and methods for their use |
| 01/31/2001 | EP1071432A1 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine |
| 01/31/2001 | EP1071425A1 Treatment of depression and pharmaceutical preparations therefor |
| 01/31/2001 | EP1071421A1 Pharmaceutical imidazole combination for locally treating vulvovaginitis and vaginosis |
| 01/31/2001 | EP1071415A2 Flutamide compositions and preparations |
| 01/31/2001 | EP1071413A1 Topical formulations for the treatment of nail fungal diseases |
| 01/31/2001 | EP1071410A1 Ionic aqueous composition containing levomenthol |
| 01/31/2001 | EP1071408A1 Microparticles for drug delivery across mucosa and the blood-brain barrier |
| 01/31/2001 | EP1071407A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same |
| 01/31/2001 | EP1071404A2 Softgel-compatible composition containing retinol |
| 01/31/2001 | EP1071403A1 Pharmaceutical composition containing a statin and aspirin |
| 01/31/2001 | EP1071402A1 Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants |
| 01/31/2001 | EP1071401A1 Liposomal bupivacaine compositions and methods of preparation |
| 01/31/2001 | EP1071400A1 Drug delivery of proteins from polymeric blends |
| 01/31/2001 | EP1071398A1 Implants for administering substances and methods of producing implants |
| 01/31/2001 | EP1071397A2 Controlled release peroral compositions of levosimendan |
| 01/31/2001 | EP1071377A1 Needleless administration of polynucleotide formulations |
| 01/31/2001 | EP0785774B1 Targeted delivery via biodegradable polymers |
| 01/31/2001 | EP0737064B1 Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
| 01/31/2001 | CN2416900Y Local applying medicine slow-released device for treating gynecopathy |
| 01/31/2001 | CN1282345A Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| 01/31/2001 | CN1282256A Novel sterilization process for pharmaceutical suspensions |
| 01/31/2001 | CN1282254A Compositions and methods for regulating phagocytosis and ICAM-1 expression |
| 01/31/2001 | CN1282251A Method and material for treating and preventing mucosal tissue inflammation |
| 01/31/2001 | CN1282250A Progestin therapy with controlled bleeding |
| 01/31/2001 | CN1282246A Rapidly soluble drug composition |
| 01/31/2001 | CN1282245A Molecular dispersion composition with enhanced bioavailability |
| 01/31/2001 | CN1282244A Pharmaceutical compositions |
| 01/31/2001 | CN1282240A Rate controlling membranes for controlled drug delivery device |
| 01/31/2001 | CN1282239A Spheroids, preparation method and pharmaceutical compositions |
| 01/31/2001 | CN1282218A Compositions and method for treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/31/2001 | CN1281726A Zhuanggu fuwei pill and its preparation method |
| 01/31/2001 | CN1281725A Zhuanggu Kuoguan pill and its preparation method |
| 01/31/2001 | CN1281719A Chinese medicine composition for curing ischemic angiocardiopathy and cerebrovascular disease and its preparation method |
| 01/31/2001 | CN1281703A Kechuan Xieling ointment |
| 01/31/2001 | CN1281702A Powder and paster for promoting blood circulation and their-matched products |
| 01/31/2001 | CN1281700A Sulfur bacterium preparation for regulating gastointestinal function and production method thereof |
| 01/31/2001 | CN1061260C Traditional Chinese medicine preparation for curing heart disease |
| 01/31/2001 | CN1061256C External-use blood pressure reducing ointment |
| 01/31/2001 | CN1061254C Medicine mixed type cigarette and producing method thereof |
| 01/31/2001 | CN1061252C Chinese medicine oxygen nebulization preparation for curing cardio-cerebral disease and preparing method |
| 01/31/2001 | CN1061248C Powder agent formula for curing acne and seborrhea and production method |
| 01/31/2001 | CN1061239C Specific curing agent for AIDS |
| 01/31/2001 | CN1061237C Traditional Chinese medicine capsule for curing epilepsy |
| 01/31/2001 | CN1061235C Pharmaceutical composition for prophlaxis and treatment of premature ejaculation caused by neuroticism |
| 01/31/2001 | CN1061230C Process for preparing 'Wujisan' granule |
| 01/30/2001 | US6180781 Process for making mometasone furoate monohydrate |
| 01/30/2001 | US6180682 Buccal drug delivery system for use in male contraception |
| 01/30/2001 | US6180663 Therapeutic nasal inhalant |
| 01/30/2001 | US6180661 Water dispersible concentrate |
| 01/30/2001 | US6180637 Therapy for parkinson, alzheimer disease |
| 01/30/2001 | US6180615 Propargyl phenyl ether A2A receptor agonists |
| 01/30/2001 | US6180608 Packaged formulation for treating a subject for a condition treatable with an lhrh analogue, comprising ionic complex of lhrh analogue and carrier macromolecule |
| 01/30/2001 | US6180603 Method for administering neurologic agents to the brain |
| 01/30/2001 | US6180601 Freeze-dried soft, flexible and continous matrix of hyaluronic acid containing peptide or protein used for wound healing |
| 01/30/2001 | US6180403 Antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression |
| 01/30/2001 | US6180389 Virion-constrained nanoparticles comprising a plant virion coat protein shell and encapsulated guest molecules |